Press Releases
Nov 6, 2018
Definiens to showcase 5 successful immuno-oncology studies at SITC 2018
Munich – November 06, 2018
Oct 18, 2018
Covance and Definiens collaborate to integrate digital pathology into precision medicine design and development
Alliance establishes image analysis-enabled companion diagnostics as standard for comprehensive targeted therapies
Oct 3, 2018
Definiens showcases pharma solutions for immuno-oncology profiling
Tissue Phenomics approach accelerates clinical trial assay development & patient profiling
Sep 10, 2018
Definiens embarks on Digital Pathology Collaboration with Merck´s exploratory and clinical development programs
Munich, Germany, September 2018 (Newswire.com)
Jul 26, 2018
Definiens strengthens digital data and science strategy by appointing Mr. Markus Schunk as Chief Operating Officer.
Mr Schunk joins Definiens with extensive experience in developing very successful digital platform and SaaS businesses